Aurinia Pharmaceuticals Inc (AUPH)
8.88
+0.11
(+1.25%)
USD |
NASDAQ |
Nov 22, 16:00
8.88
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Assets (Quarterly): 549.36M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 549.36M |
| June 30, 2024 | 523.53M |
| March 31, 2024 | 516.63M |
| December 31, 2023 | 548.06M |
| September 30, 2023 | 555.01M |
| June 30, 2023 | 548.90M |
| March 31, 2023 | 451.76M |
| December 31, 2022 | 470.86M |
| September 30, 2022 | 488.29M |
| June 30, 2022 | 482.15M |
| March 31, 2022 | 506.90M |
| December 31, 2021 | 543.37M |
| September 30, 2021 | 360.07M |
| June 30, 2021 | 386.27M |
| March 31, 2021 | 417.08M |
| December 31, 2020 | 463.66M |
| September 30, 2020 | 461.75M |
| June 30, 2020 | 295.28M |
| March 31, 2020 | 314.97M |
| December 31, 2019 | 324.30M |
| September 30, 2019 | 150.84M |
| June 30, 2019 | 151.24M |
| March 31, 2019 | 164.50M |
| December 31, 2018 | 145.86M |
| September 30, 2018 | 157.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 167.86M |
| March 31, 2018 | 176.41M |
| December 31, 2017 | 189.85M |
| September 30, 2017 | 199.83M |
| June 30, 2017 | 207.80M |
| March 31, 2017 | 219.69M |
| December 31, 2016 | 57.00M |
| September 30, 2016 | 33.25M |
| June 30, 2016 | 30.19M |
| March 31, 2016 | 27.75M |
| December 31, 2015 | 33.57M |
| September 30, 2015 | 38.94M |
| June 30, 2015 | 44.38M |
| March 31, 2015 | 48.01M |
| December 31, 2014 | 52.38M |
| September 30, 2014 | 56.40M |
| June 30, 2014 | 60.18M |
| March 31, 2014 | 63.28M |
| December 31, 2013 | 23.17M |
| September 30, 2013 | 23.33M |
| June 30, 2013 | 3.874M |
| March 31, 2013 | 3.644M |
| December 31, 2012 | 4.158M |
| September 30, 2012 | 7.740M |
| June 30, 2012 | 9.004M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
295.28M
Minimum
Jun 2020
555.01M
Maximum
Sep 2023
460.41M
Average
476.50M
Median
Total Assets (Quarterly) Benchmarks
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 132.67M |
| ImmunoPrecise Antibodies Ltd | 42.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 161.36M |
| Shareholders Equity (Quarterly) | 388.00M |
| Current Ratio | 5.603 |